Kappa Bioscience
History

The History of K2

Vitamin K2- History of the missing Vitamin


The History of K2 - Basic Principals

See what CEO Egil Greve from Kappa Bioscience has to say about K2


Play video


1600s

The history of vitamin K2 spans centuries and continents, back to feudal Japan where Samurai warriors consumed a fermented soybean dish called natto.

Historical diets probably provided enough K2. Changes in food preparation and storage due to industrialization have likely diminished the amount of vitamin K2 available in our diets. Vitamin K2 went unnoticed until its absence began to be recognized.

1930s

Vitamin K family discovered. In 1935 Danish scientist Henrik Dam described a fat-soluble factor that reduced bleeding in chicks fed an extremely low-fat diet. He named this factor vitamin K after the German and Danish word for coagulation (koagulation).
A few years later, American biochemist Edward Adelbert Doisy determined the chemical structure of vitamin K and succeeded in synthesizing it.

1943

For their pioneering work, Dam and Doisy shared the 1943 Nobel Prize in Medicine. Dam and Doisy discovered vitamin K1 (phylloquinone). Years later vitamin K2 (menaquinone) was recognized. Vitamin K2 is comprised of a group of several different molecules forms, with side chains of 4 to 14 isoprenoid units. These mostly unsaturated molecules were first identified in the 1950s. Around this time W. Price discovered ‘Activator X’ (K2) as missing ingredient for tooth and bone health.

1950s

Recognition of vitamin K2 as a group of molecules with differing contribution to health.

1960s

Vitamin K2 as MK-4 approved as a drug in Japan.

1970s

Vermeer started scientific work on enzymes and coagulation.

1990s

Rediscovery of vitamin K2. Despite this early progress, vitamin K2 was largely overlooked for a number of years before being rediscovered. This new awakening also had roots in Japan, with investigations as early as 1990 by Motohara et al. studying the transfer of vitamin K2 between mothers and newborns.

2000s

Studies initiated investigat ing K2 and bone health and K2 biomarkers. In the 2000s several Japanese studies investigating the link between K2 and bone health were published. Research by Katsuyama et al. in 2001 and 2002 investigated the effect of natto intake on bone stiffness and hip fracture. A wide range of studies were conducted on K2 biomarkers from 1999, demonstrating the role of vitamin K2 in activating K-dependent proteins.

2015

Demonstration of K2’s effects on cardiovascular health. Studies in 2015 by Knapen et al. and Kurnatowska et al. demonstrated reductions in arterial stiffness and the slowing of arterial calcification – reducing cardio - vascular risk.

2016

The bioequivalence of synthesized and natural-fermented was proven. Møller et al. demonstrated in 2016 that synthesized vitamin K2 K2VITAL® and natural-fermented K2 are biologically equivalent, including mechanisms of action and biological outcomes.

 

  • Science Papers
  • Basic Principals

K2 Introduction

More information

The History of K2

More information

The Different Vitamins in the K Family

More information

All-trans Means All-bioactive

More information

K2 Deficiency

More information

Customer Download Portal

Sign up | Reset password

Sales and Marketing
Kappa Ingredients GmbH
Deichstrasse 29 | 20459 Hamburg
Germany

Headquarter
Kappa Bioscience AS
Silurveien 2 | Building B | 0380 Oslo
Norway

+49 40 6094087 0